Navigation Links
HOYA ConBio Announces Educational Agreement With LVI Global
Date:2/20/2008

HOYA ConBio Lasers Featured At Premier Las Vegas Training Facility

FREMONT, Calif., Feb. 20 /PRNewswire/ -- HOYA ConBio(TM), a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI), an internationally recognized leader in post-graduate dental education, in which VersaWave(TM) and DioDent(TM) Micro 980 lasers will be utilized at LVI's state-of-the-art teaching facility through 2009. The educational alliance is the latest development in HOYA ConBio's corporate outreach to partner with pioneers in dental continuing education.

"In the past, we've selected LVI as the host site for our HOYA ConBio College for laser dentistry training," said Timothy S. Gehlmann, President & CEO, HOYA ConBio. "This agreement takes our relationship to a new level and we are excited to move forward with comprehensive laser course offerings, providing a complete portfolio of products to achieve superior clinical results."

HOYA ConBio's VersaWave and DioDent Micro 980 dental lasers will be placed at LVI's 62,000 square-foot facility, which features two 10-operatory teaching clinics, a 60 bench hands-on workshop and six lecture halls. According to William G. Dickerson, DDS, LVI Global's founder and CEO, practicing dentists worldwide visit LVI to advance their education, knowledge and expertise in aesthetic, neuromuscular, occlusal, restorative and reconstruction dentistry.

"We share HOYA ConBio's belief that training is paramount to successful dentistry and we are pleased to feature their dental lasers at our first-class facility," commented Dennis Bonilla, LVI Global President. "Since 1995, LVI has set standards for clinical education in dentistry and our graduates are among the finest, most progressive dentists in the world. HOYA ConBio's dental lasers will be an integral part of our curriculum, available to the more than 6,000 LVI clinical alumni who attend our courses to le
'/>"/>

SOURCE HOYA ConBio
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
4. XTENT Announces 2007 Financial Results
5. VA Secretary Announces New Walla Walla Facility
6. TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States
7. Pennsylvania Department of Public Welfare Announces Grant Opportunity for Regional Autism Centers
8. Paine & Partners, LLC Announces Sale of Byram Healthcare to OPG Groep N.V.
9. MedCath Announces Venture With Two New Jersey Hospitals
10. Nu Skin Enterprises Announces Increase in Quarterly Dividend
11. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created ...l companies reported a different kind of slowdown:...us months. , Seattle, WA ... created in the medical field slowed in June overa...kind of slowdown that will be music to the ears of...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begins -...-- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a l... today that its subsidiary has commenced commercia...les USP product in the 40mg,strength from its Davi...with the launch, Watson has 180 days of marketing ...
(Date:7/25/2008)...BURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmac...eutical company, today announced that it,has launc...iarrhythmic,indicated for the treatment and prophy...tion and hemodynamically unstable ventricular,tach...r heart beat.,Sagent,s amiodarone HCl injection wi...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...have found that twins are performing on par with o...e. Previously the performance of the twins// has b...other average students. Researchers felt this was ...rom parents as well as have low educational motiva...
...s: Suicide rates among younger and older Americans...he puzzling news: No one really knows why// . Tho...chers at the University of South Carolina and rele... the October issue of the American Journal of Publ...
... by scientists at the Broad Institute of MIT and H...nd of genetic “roadmap” that can connect human dis...l as predict how new drugs work in human cells. Ca... uses are described in the September 29 issue of S...
...ns faculty members performing microsurgery in Tanz...ting room, or health care experts// in Vietnam pre...ents gathered in the Hopkins outpatient center. Th...gh-tech Internet communication system that will be...
Other Medicine News:Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
(Date:7/24/2008)...Circulating Tumor Cells, RARITAN, N.J., July 25 /...cal trial found the number of circulating tumor ce...ee and overall survival among metastatic,colorecta... in the July 1,issue of the Journal of Clinical On...erlands, and the United,Kingdom, found that metast...
(Date:7/24/2008)...SNewswire/ -- Headlines claiming "soy,products low...mall scale,preliminary study that Dr. Jorge Chava...sed on recollected intake of soyfoods and not on,s...confounded by many,issues, thus I feel the results...arned Dr. Tammy Hedlund, a researcher in prostate ...
(Date:7/23/2008)...mic Therapy to Treat the Disease -, WAYNE, N.J. a...ll/ --,Bayer HealthCare Pharmaceuticals and Onyx P...d that The New England Journal of Medicine publish...exavar(R) (sorafenib),tablets decreased the absolu...resectable hepatocellular carcinoma (HCC), or live...
(Date:7/23/2008)...e Body Have Greater Concentrations of,Stem Cells, ...wswire/ -- Fat removed,from the lower abdomen and ... excellent source of stem cells, with higher stem ...reports a Brazilian-based study in August,s,Plasti...cal journal of the,American Society of Plastic Sur...
Breaking Medicine Technology:Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 2Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 3Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 1Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 2Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 3Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 4Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 5Celebrities and Notables From the Worlds of Film Television Music and Sports Join Lifetime Televisions 13th Annual Multi Platform Stop Breast Cancer 995 6New transfusion rules restrict donations from previously pregnant women 2632 1New transfusion rules restrict donations from previously pregnant women 2632 2New transfusion rules restrict donations from previously pregnant women 2632 3AGD Applauds Congressional Support of SCHIP Reauthorization 2630 1AGD Applauds Congressional Support of SCHIP Reauthorization 2630 2Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 1Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 2Dr Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication Quality Research in Health Care 2628 3
...--Mar 26, 2007 - A study comparing,the formulation...HYD) used in V-HeFT I and V-HeFT II, and BiDil, th...African American Heart Failure,Trial (A-HeFT) demo...the formulations used may explain why V-HeFT I and...sing mortality. Using,identical amounts of active ...
...being treated with maximally,tolerated lipid-lower...n LDL-C with similar reductions in other atherogen...ORLEANS, and CARLSBAD, Calif., March 26, 2007,/PRN...nnounced,results from its ongoing Phase 2 clinical...familial hypercholesterolemia (HoFH),presented to...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
The Libert Coronary Stent System introduces a new generation of lesion access and conformability. With exceptional flexibility, a low crossing profile, and the leading delivery catheter, the performa
..., and microplatesthat is the area of research in w...increasing force. Ergonomics (reduced weight and e...nel Research model was developed. This high-perfor... precise, and rapid processing of long series for ...
The Finnpipette Digital Multichannel, with it's streamlined design, makes even lighter work of routine laboratory tasks. The multichannel offers all these advanced features: Soft-touch tip ejection,
...mics, and value!, Comfortable feel and less hand ...er control while pipetting with smooth, light plun...long, lever tip ejector , Completely autoclavable ... the need for recalibration , Easy-to-read precisi...
Medicine Products: